Monday, July 02, 2018 9:19:00 PM
First, assume that a company without revenue who finds a big reservoir will not have cash flow for some amount of time to pay for operations and provide capital.
Therefore, outside financing has to be considered and there are two paths:
A. Borrow funds (debt), or
B. Issue shares (equity).
Both A and B dilute the future value of the shares, but in different ways.
A reduces earnings per share due to interest payments, but with fewer shares outstanding.
B increases the shares outstanding, so the earnings are spread over additional shares, lowering earnings per share.
From a pure accounting standpoint, an optimum point between debt and equity can be found which maximizes earnings per share, which in turn maximizes the price per share.
However, from an operational standpoint the two paths behave very differently. I worked for an S&P 500 company in the computer industry that took on debt to reduce shares which put the dividend payment at risk during a downturn. The company might have done considerably better had it been able to use cash flow to raise the dividend or invest internally. Later, I was in the oil industry and saw first hand the impact on cash flow when oil went from $100/bll to $25/bll. Many players were wiped out due to high interest payments.
So, from an accounting standpoint, I agree that debt issues could maximize earnings per share for a range of scenarios. However, from an operational standpoint I would much prefer to be with a company that grew with equity issues and was debt-free. That company can weather storms with a positive earnings per share.
Recent ZNOG News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/22/2024 09:17:16 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/22/2024 09:16:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 08:30:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 08:00:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 07:38:34 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/26/2024 07:37:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 04:44:22 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/29/2024 04:43:39 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/25/2024 07:42:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 02:54:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 09:31:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 07:45:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 07:33:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 07:26:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 07:19:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 07:08:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 06:58:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 04:50:59 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/20/2023 04:49:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 07:38:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 05:43:07 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 02:38:05 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/06/2023 02:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2023 03:35:05 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM